Abstract:Objective To evaluate the effect of Dexmedetomidine on controlling hypertensive during endoscopic sinus surgery. Methods A total of 60 patients under ASA I/II received general anesthesia for elective endoscopic sinus surgery. Patients were randomly divided into two groups: Dexmedetomidine group (group D) and normal saline control group (group C) (n?=?30). In group D, a loading dose of Dexmedetomidine 1.0?μg/kg was injected intravenously over 15?min before induction, followed by continuous infusion at 0.4?μg/(kg?h) until the end of the operation. While patients in group C received the equal volume of normal saline. The two groups were kept under the continuous infusion of Propofol and remifentanil for standard general anesthesia. SBP, DBP, HR, and IOP at the time of pre-anesthesia (T0), endotracheal intubation (T1), 30?min after controlled hypotension to the target blood pressure (T2), drug withdrawal (T3), and 20?min after drug withdrawal (T4) were recorded. At the time of T0 and T4, venous blood sample was collected for hemoglobin detection. Propofol dosage, recovery time and adverse reaction were recorded in two groups. In PACU, the patient was assessed for a sedative score. Results The heart rate of group C was higher than that of group D at T1-T4 (P?0.05). At T1, MAP, HR and IOP in group C were increased than those in group D (P?0.05). At the time of T2 and T3, the MAP stabilized at 60 to 70?mmHg. At T4, MAP, HR and IOP of group C were increased than those of the group D. Compared with group C, the scores of operative fields, propofol dosage, respiratory recovery time, and postoperative hemoglobin change in group D were lowered than those in group C (P?0.05). There was no significant difference in extubation time between the two groups. The sedation score at PACU was significantly higher in group D than that in group C. The incidence of agitation in group D was decreased than that in group C. Conclusions Dexmedetomidine is safe and effective for controling hypertension in endoscopic sinus surgery.